Thanks for that , Good article update, things happening behind...

Thanks for that , Good article update, things happening behind the scenes which is good.


The subsequent EU-GMP certification is due in August 2020 and will allow HAPA to sell its pharmaceutical cannabis products within the European Union.

HAPA pharm is the first German company to cover the full value chain of cannabinoid pharmaceuticals – from growing, packaging and manufacturing of extracts and dried flower to international sales.

The company is well positioned to benefit from the rising global demand for pharmaceutical cannabis products.